Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Astrazeneca Plc (AZN)

Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Forget the Endless AI Stock Debate: This Outperforming Sector is the One to Watch Now

Our top chart strategist explains what investors are missing amid all the chatter over software stocks and AI spending; plus, his favorite stock to trade right now.

AA : 59.69 (-0.86%)
GOOG : 303.56 (-0.13%)
GOOGL : 302.85 (-0.16%)
AZN : 208.62 (-0.02%)
INTC : 44.62 (-1.85%)
IGV : 81.78 (-0.27%)
^BTCUSD : 67,346.23 (+0.64%)
MWH : 30.50 (-0.91%)
Why Wedbush Thinks Norway Could Be Key for This Quantum Computing Stock -- and the Entire Industry

Norway's sovereign wealth fund invested $200 million in IonQ, $39 million in Rigetti, and $4 million in D-Wave. Wedbush sees this as a potential turning point for institutional investment in quantum computing...

MSFT : 398.46 (-0.29%)
GOOG : 303.56 (-0.13%)
GOOGL : 302.85 (-0.16%)
QBTS : 19.38 (+1.63%)
SKYT : 28.83 (+0.31%)
AZN : 208.62 (-0.02%)
IONQ : 33.43 (+0.27%)
RGTI : 16.60 (+2.60%)
AMZN : 204.86 (+0.03%)
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine

Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol...

AZN : 208.62 (-0.02%)
AZN.LN : 15,289.998 (-1.62%)
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

ZBH : 99.25 (+1.02%)
EW : 78.92 (-0.08%)
AZN : 208.62 (-0.02%)
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US

US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date

AZN : 208.62 (-0.02%)
AZN.LN : 15,289.998 (-1.62%)
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END

HELP : 6.90 (-2.82%)
AZN : 208.62 (-0.02%)
JNJ : 246.91 (+0.78%)
HELP.NE : 9.5000 (-2.56%)
ABBV : 224.35 (-1.91%)
TAK : 18.66 (+0.65%)
AstraZeneca results: FY and Q4 2025

Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period

AZN : 208.62 (-0.02%)
AZN.LN : 15,289.998 (-1.62%)
Is This the End of the Road for Google Stock? Plus, QQQ’s 100-Day Moving Average Break

Find out what’s on the desk of our top chart expert ahead of Friday’s livestream, including a new red flag on Google stock, a big breakout in BALL, and key ETF updates.

QQQ : 603.47 (-0.38%)
GOOG : 303.56 (-0.13%)
GOOGL : 302.85 (-0.16%)
NVDA : 187.90 (-0.04%)
BALL : 66.03 (-0.42%)
FSLR : 233.30 (-2.21%)
AZN : 208.62 (-0.02%)
MMM : 165.05 (+0.54%)
Bullish Price Surprise: GameStop’s Ryan Cohen Is No Warren Buffett

Michael Burry made a fortune betting against the U.S. housing market. He believes GameStop CEO Ryan Cohen is a Warren Buffett in waiting. Here are three reasons why that’s not the case and why bullish...

AAPL : 260.58 (-1.43%)
COST : 987.82 (-0.83%)
AZN : 208.62 (-0.02%)
WFC : 87.57 (-1.12%)
BRK.B : 496.94 (-0.43%)
KR : 67.63 (-1.79%)
CHWY : 25.86 (+6.99%)
GME : 23.90 (+0.13%)
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

Based on results from TROPION-Breast02, showing AstraZeneca and Daiichi Sankyo’s DATROWAY significantly improved overall survival vs. chemotherapy in this patient population ...

AZN : 208.62 (-0.02%)
AZN.LN : 15,289.998 (-1.62%)

Barchart Exclusives

Kraft Heinz Pauses Its Breakup Plans. Should You Buy the High-Yield Dividend Stock Here?
Kraft Heinz is still facing many tough challenges. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar